![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1385, 2012-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statins increase risk of incident hip osteoarthritis
Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statins do not increase the risk of amyotrophic lateral sclerosis
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers increase risk of diabetes mellitus
Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statin therapy associated with 9% increase in diabetes risk
Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Statins and New-Onset Diabetes
Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. :